提案スペルによる検索:
"oto opens" » "oto open" (検索語の拡大), "both opens" (検索語の拡大), "o opens" (検索語の拡大), "otdo opens" (検索語の拡大), "oto openss" (検索語の拡大), "otso opens" (検索語の拡大)
"ao open" » "do open" (検索語の拡大), "so open" (検索語の拡大), "caso open" (検索語の拡大), "ado open" (検索語の拡大), "ao opens" (検索語の拡大), "aso open" (検索語の拡大)
"l1 open" » "1 open" (検索語の拡大)
"esmo open" » "esmdo open" (検索語の拡大), "esmo opens" (検索語の拡大), "esmso open" (検索語の拡大), "esto open" (検索語の拡大), "eso open" (検索語の拡大), "ecmo open" (検索語の拡大)
"o open" » "do open" (検索語の拡大), "o opens" (検索語の拡大), "so open" (検索語の拡大)
検索結果 1 - 20 結果 / 1,267 検索語 '(("esmo open") OR ((((("ao open") OR ("l1 open"))) OR ((("o open") OR ("oto opens"))))))', 処理時間: 4.93秒 結果の絞り込み
Presenting OTO Open
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

ESMO Open—Cancer Horizons and the future of oncology
CSCO joins ESMO Open—Cancer Horizons

ESMO Open: news in breast cancer 2019
ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

ESMO Open special series on new emerging targets in cancer immunotherapy
Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

One year of ESMO Open: Cancer Horizons—where are we going from here?
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

Nucleotide sequence of the HPV16 L1 open reading frame.
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
Phylogenetic position of an uncharacterized Brazilian strain of bovine papillomavirus in the genus Xipapillomavirus based on sequencing of the L1 open reading frame

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]
Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’: [ESMO Open Volume 6, Issue 1, February 2021, 100005]

検索ツール: RSSフィード — 検索結果をメール — 検索の保存